The revolutionary MolecuLight i:X Wound Imaging Device receives CE Mark approval

September 16, 2016 -The MolecuLight i:X Imaging Device can instantly visualize potentially harmful bacteria at the point of care

TORONTO – September 16, 2016 – MolecuLight Inc. has received CE Mark approval authorizing commercial sales in the European Union of its MolecuLight i:X Imaging Device, that is revolutionizing wound care.

The MolecuLight i:X will be making

Read More

Next